Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?

Inflamm Bowel Dis. 2018 May 18;24(6):1193-1195. doi: 10.1093/ibd/izy033.

Authors

P Veyrard¹, G Boschetti², S Nancey², X Roblin¹

Affiliations

¹ Department of Gastroenterology, University Hospital of Saint Etienne, France.
² Department of Gastroenterology, University Hospital of Lyon, France.

PMID: 29668995
DOI: 10.1093/ibd/izy033

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal, Humanized / drug effects*
Clinical Trials, Phase III as Topic
Crohn Disease / drug therapy*
Humans
Precision Medicine / methods
Predictive Value of Tests

Substances

Antibodies, Monoclonal, Humanized
vedolizumab